CLINICAL_TRIALS
research
· 2026-04-15
Clinical Trial Update: A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplantation
Summary
Karolinska Institutet is conducting a national Swedish study to evaluate donor-derived cell-free DNA as a diagnostic biomarker for rejection surveillance in hea…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Karolinska Institutet | Conditions: Heart Transplantation, Heart Transplant Rejection | Status: RECRUITING